These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38277301)

  • 1. Break Down of the Complexity and Inconsistency Between Levels of Matriglycan and Disease Phenotype in FKRP-Related Dystroglycanopathies: A Review and Model of Interpretation.
    Lu QL; Holbrook MC; Cataldi MP; Blaeser A
    J Neuromuscul Dis; 2024; 11(2):275-284. PubMed ID: 38277301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fukutin-Related Protein: From Pathology to Treatments.
    Ortiz-Cordero C; Azzag K; Perlingeiro RCR
    Trends Cell Biol; 2021 Mar; 31(3):197-210. PubMed ID: 33272829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies.
    Chan YM; Keramaris-Vrantsis E; Lidov HG; Norton JH; Zinchenko N; Gruber HE; Thresher R; Blake DJ; Ashar J; Rosenfeld J; Lu QL
    Hum Mol Genet; 2010 Oct; 19(20):3995-4006. PubMed ID: 20675713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A universal gene correction approach for FKRP-associated dystroglycanopathies to enable autologous cell therapy.
    Dhoke NR; Kim H; Selvaraj S; Azzag K; Zhou H; Oliveira NAJ; Tungtur S; Ortiz-Cordero C; Kiley J; Lu QL; Bang AG; Perlingeiro RCR
    Cell Rep; 2021 Jul; 36(2):109360. PubMed ID: 34260922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAD+ enhances ribitol and ribose rescue of α-dystroglycan functional glycosylation in human FKRP-mutant myotubes.
    Ortiz-Cordero C; Magli A; Dhoke NR; Kuebler T; Selvaraj S; Oliveira NA; Zhou H; Sham YY; Bang AG; Perlingeiro RC
    Elife; 2021 Jan; 10():. PubMed ID: 33513091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adeno-associated virus-mediated overexpression of LARGE rescues α-dystroglycan function in dystrophic mice with mutations in the fukutin-related protein.
    Vannoy CH; Xu L; Keramaris E; Lu P; Xiao X; Lu QL
    Hum Gene Ther Methods; 2014 Jun; 25(3):187-96. PubMed ID: 24635668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revertant Phenomenon in DMD and LGMD2I and Its Therapeutic Implications: A Review of Study Under Mentorship of Terrence Partridge.
    Lu QL
    J Neuromuscul Dis; 2021; 8(s2):S359-S367. PubMed ID: 34151854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal muscle development in a mouse model for the secondary dystroglycanopathies.
    Kim J; Hopkinson M; Kavishwar M; Fernandez-Fuente M; Brown SC
    Skelet Muscle; 2016; 6():3. PubMed ID: 26900448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribitol dose-dependently enhances matriglycan expression and improves muscle function with prolonged life span in limb girdle muscular dystrophy 2I mouse model.
    Wu B; Drains M; Shah SN; Lu PJ; Leroy V; Killilee J; Rawls R; Tucker JD; Blaeser A; Lu QL
    PLoS One; 2022; 17(12):e0278482. PubMed ID: 36454905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new patient-derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α-dystroglycan.
    Kim J; Lana B; Torelli S; Ryan D; Catapano F; Ala P; Luft C; Stevens E; Konstantinidis E; Louzada S; Fu B; Paredes-Redondo A; Chan AE; Yang F; Stemple DL; Liu P; Ketteler R; Selwood DL; Muntoni F; Lin YY
    EMBO Rep; 2019 Nov; 20(11):e47967. PubMed ID: 31566294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved efficacy of FKRP AAV gene therapy by combination with ribitol treatment for LGMD2I.
    Cataldi MP; Vannoy CH; Blaeser A; Tucker JD; Leroy V; Rawls R; Killilee J; Holbrook MC; Lu QL
    Mol Ther; 2023 Dec; 31(12):3478-3489. PubMed ID: 37919902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAD+ improves neuromuscular development in a zebrafish model of FKRP-associated dystroglycanopathy.
    Bailey EC; Alrowaished SS; Kilroy EA; Crooks ES; Drinkert DM; Karunasiri CM; Belanger JJ; Khalil A; Kelley JB; Henry CA
    Skelet Muscle; 2019 Aug; 9(1):21. PubMed ID: 31391079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression in retinal neurons of fukutin and FKRP, the protein products of two dystroglycanopathy-causative genes.
    Haro C; Uribe ML; Quereda C; Cruces J; Martín-Nieto J
    Mol Vis; 2018; 24():43-58. PubMed ID: 29416295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient engraftment of pluripotent stem cell-derived myogenic progenitors in a novel immunodeficient mouse model of limb girdle muscular dystrophy 2I.
    Azzag K; Ortiz-Cordero C; Oliveira NAJ; Magli A; Selvaraj S; Tungtur S; Upchurch W; Iaizzo PA; Lu QL; Perlingeiro RCR
    Skelet Muscle; 2020 Apr; 10(1):10. PubMed ID: 32321586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribitol enhances matriglycan of α-dystroglycan in breast cancer cells without affecting cell growth.
    Lu PJ; Tucker JD; Branch EK; Guo F; Blaeser AR; Lu QL
    Sci Rep; 2020 Mar; 10(1):4935. PubMed ID: 32188898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of Functional Glycosylation of α-Dystroglycan in FKRP Mutant Mice Is Associated with Muscle Regeneration.
    Awano H; Blaeser A; Keramaris E; Xu L; Tucker J; Wu B; Lu P; Lu QL
    Am J Pathol; 2015 Jul; 185(7):2025-37. PubMed ID: 25976249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of glycosylated α-dystroglycan in newborn skeletal and cardiac muscles of fukutin related protein (FKRP) mutant mice.
    Keramaris E; Lu PJ; Tucker J; Lu QL
    Muscle Nerve; 2017 Apr; 55(4):582-590. PubMed ID: 27515093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse models of fukutin-related protein mutations show a wide range of disease phenotypes.
    Blaeser A; Keramaris E; Chan YM; Sparks S; Cowley D; Xiao X; Lu QL
    Hum Genet; 2013 Aug; 132(8):923-34. PubMed ID: 23591631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dystroglycanopathy muscles lacking functional glycosylation of alpha-dystroglycan retain regeneration capacity.
    Awano H; Blaeser A; Wu B; Lu P; Keramaris-Vrantsis E; Lu Q
    Neuromuscul Disord; 2015 Jun; 25(6):474-84. PubMed ID: 25937147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FKRP directed fibronectin glycosylation: A novel mechanism giving insights into muscular dystrophies?
    Boyd A; Montandon M; Wood AJ; Currie PD
    Bioessays; 2022 May; 44(5):e2100270. PubMed ID: 35229908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.